These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 18302713

  • 1. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
    Chaudhury S, Auerbach AD, Kernan NA, Small TN, Prockop SE, Scaradavou A, Heller G, Wolden S, O'Reilly RJ, Boulad F.
    Br J Haematol; 2008 Mar; 140(6):644-55. PubMed ID: 18302713
    [Abstract] [Full Text] [Related]

  • 2. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts.
    Boulad F, Gillio A, Small TN, George D, Prasad V, Torok-Castanza J, Regan AD, Collins N, Auerbach AD, Kernan NA, O'Reilly RJ.
    Br J Haematol; 2000 Dec; 111(4):1153-7. PubMed ID: 11167755
    [Abstract] [Full Text] [Related]

  • 3. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
    Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF.
    N Engl J Med; 1998 Oct 22; 339(17):1186-93. PubMed ID: 9780338
    [Abstract] [Full Text] [Related]

  • 4. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH, Lee JH, Lee JH, Kim DY, Kim SH, Shin HJ, Lee YS, Kang YA, Seol M, Ryu SG.
    Biol Blood Marrow Transplant; 2009 Jan 22; 15(1):61-72. PubMed ID: 19135944
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia.
    Yabe H, Inoue H, Matsumoto M, Hamanoue S, Koike T, Ishiguro H, Koike H, Suzuki K, Kato S, Kojima S, Tsuchida M, Mori T, Adachi S, Tsuji K, Koike K, Morimoto A, Sako M, Yabe M.
    Br J Haematol; 2006 Jul 22; 134(2):208-12. PubMed ID: 16846479
    [Abstract] [Full Text] [Related]

  • 6. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
    Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab JP, Santucci A, Perruccio K, Martelli MP, Mecucci C, Reisner Y, Martelli MF.
    J Clin Oncol; 2005 May 20; 23(15):3447-54. PubMed ID: 15753458
    [Abstract] [Full Text] [Related]

  • 7. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML.
    Pediatr Blood Cancer; 2006 May 01; 46(5):630-6. PubMed ID: 16078221
    [Abstract] [Full Text] [Related]

  • 8. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
    de la Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IA, Rahemtulla A, Dokal I.
    Bone Marrow Transplant; 2003 Oct 01; 32(7):653-6. PubMed ID: 13130311
    [Abstract] [Full Text] [Related]

  • 9. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience.
    Farzin A, Davies SM, Smith FO, Filipovich A, Hansen M, Auerbach AD, Harris RE.
    Br J Haematol; 2007 Feb 01; 136(4):633-40. PubMed ID: 17367413
    [Abstract] [Full Text] [Related]

  • 10. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA, Faul C, Bornhäuser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hägele M, Handgretinger R, Kanz L.
    Blood Cells Mol Dis; 2008 Feb 01; 40(1):13-9. PubMed ID: 17869547
    [Abstract] [Full Text] [Related]

  • 11. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
    Novitzky N, Thomas V, du Toit C, McDonald A.
    Bone Marrow Transplant; 2009 May 01; 43(10):779-85. PubMed ID: 19079315
    [Abstract] [Full Text] [Related]

  • 12. Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia.
    Aversa F, Terenzi A, Felicini R, Tabilio A, Falzetti F, Carotti A, Falcinelli F, Sodani P, Amici A, Zucchetti P, Mazzarino I, Martelli MF.
    Bone Marrow Transplant; 1998 Dec 01; 22 Suppl 5():S29-32. PubMed ID: 9989886
    [Abstract] [Full Text] [Related]

  • 13. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
    Zecca M, Strocchio L, Pagliara D, Comoli P, Bertaina A, Giorgiani G, Perotti C, Corbella F, Brescia L, Locatelli F.
    Biol Blood Marrow Transplant; 2014 Apr 01; 20(4):571-6. PubMed ID: 24462983
    [Abstract] [Full Text] [Related]

  • 14. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH.
    Biol Blood Marrow Transplant; 2007 Jul 01; 13(7):790-805. PubMed ID: 17580257
    [Abstract] [Full Text] [Related]

  • 15. Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin.
    Ortín M, Raj R, Kinning E, Williams M, Darbyshire PJ.
    Bone Marrow Transplant; 2002 Sep 01; 30(6):359-66. PubMed ID: 12235520
    [Abstract] [Full Text] [Related]

  • 16. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
    Ayas M, Al-Seraihi A, El-Solh H, Al-Ahmari A, Khairy A, Aldali A, Markiz S, Siddiqui K, Al-Jefri A.
    Biol Blood Marrow Transplant; 2012 Apr 01; 18(4):627-32. PubMed ID: 21871862
    [Abstract] [Full Text] [Related]

  • 17. Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation.
    Rossi G, Giorgiani G, Comoli P, Nobili B, Salvaneschi L, De Stefano P, Maccario R, Locatelli F.
    Bone Marrow Transplant; 2003 Mar 01; 31(6):437-40. PubMed ID: 12665837
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors.
    Matsuda Y, Hara J, Osugi Y, Fujisaki H, Takai K, Ohta H, Nakanishi K, Tokimasa S, Miyoshi H, Tanaka-Taya K, Yamanishi K, Okada S.
    Bone Marrow Transplant; 1998 Feb 01; 21(4):355-60. PubMed ID: 9509968
    [Abstract] [Full Text] [Related]

  • 19. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander AR.
    Exp Hematol; 2008 Aug 01; 36(8):1047-54. PubMed ID: 18456390
    [Abstract] [Full Text] [Related]

  • 20. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Aug 01; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.